CTOs on the Move

PetVivo

www.petvivo.com

 
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.petvivo.com
  • 5251 Edina Industrial Boulevard
    Minneapolis, MN USA 55439
  • Phone: 952.405.6216

Executives

Name Title Contact Details
David Masters
 Director of Science and Technology Profile

Similar Companies

Tristar Dental Laboratory

Tristar Dental Laboratory, Inc. is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

edmonds womens clinic

edmonds womens clinic is a Edmonds, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EvoEndo

EvoEndo develops systems that enable unsedated endoscopic procedures through a combination of sterile single-use, multi-specialty flexible endoscopes; VR-based patient distraction; and a comprehensive software integration platform.

RyMed Technologies

RyMed Technologies is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediBeacon

MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.